Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion
Viruses · 2023
DOI: 10.3390/v15010176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Mikhail Salnikov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Western University, London, ON N6A 3K7, Canada. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epstein-Barr Virus Infections, Carcinoma. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) is a gamma-herpesvirus associated with 10% of all gastric cancers (GCs) and 1.5% of all human cancers. EBV-associated GCs (EBVaGCs) are pathologically and clinically distinct entities from EBV-negative GCs (EBVnGCs), with EBVaGCs exhibiting differential molecular pathology, treatment response, and patient prognosis. However, the tumor immune landscape of EBVaGC has not been well explored. In this study, a systemic and comprehensive analysis of gene expression and immune landscape features was performed for both EBVaGC and EBVnGC. EBVaGCs exhibited many aspects of a T cell-inflamed phenotype, with greater T and NK cell infiltration, increased expression of immune checkpoint markers (BTLA, CD96, CTLA4, LAG3, PD1, TIGIT, and TIM3), and multiple T cell effector molecules in comparison with EBVnGCs. EBVaGCs also displayed a higher expression of anti-tumor immunity factors (PDL1, CD155, CEACAM1, galectin-9, and IDO1). Six EBV-encoded miRNAs (miR-BARTs 8-3p, 9-5p, 10-3p, 22, 5-5p, and 14-3p) were strongly negatively correlated with the expression of immune checkpoint receptors and multiple markers of anti-tumor immunity. These profound differences in the tumor immune landscape between EBVaGCs and EBVnGCs may help explain some of the observed differences in pathological and clinical outcomes, with an EBV-positive status possibly being a potential biomarker for the application of immunotherapy in GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Western University, London, ON N6A 3K7, Canada.
- Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
- Department of General Surgery, Western University, London, ON N6A 3K7, Canada.
- Department of Oncology, Western University, London, ON N6A 3K7, Canada.
- London Regional Cancer Program, Lawson Health Research Institute, London, ON N6A 5W9, Canada.
- Department of Otolaryngology, Western University, London, ON N6A 5W9, Canada.
ORCID-Profile: Mikhail Salnikov, Martin A Prusinkiewicz, Joe S Mymryk
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Salnikov, M., Prusinkiewicz, M. A., Lin, S., Ghasemi, F., Cecchini, M. J., & Mymryk, J. S. (2023). Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion. Viruses. https://doi.org/10.3390/v15010176
Vancouver
Salnikov M, Prusinkiewicz MA, Lin S, Ghasemi F, Cecchini MJ, Mymryk JS. Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion. Viruses. 2023. doi:10.3390/v15010176
BibTeX
@article{Salnikov2023,
author = {Salnikov, Mikhail and Prusinkiewicz, Martin A and Lin, Sherman and Ghasemi, Farhad and Cecchini, Matthew J and Mymryk, Joe S},
title = {Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010176}
}
EUVIMED